Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FL01C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,611
Award facts
- Contract value 100% obligated
- $71,610.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded October 30, 2025, to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), provides HEPLISAV-B 20 mcg/0.5 ml syringes with a contract ceiling value of $71,610.80 and firm fixed pricing. The award represents a competitive procurement with no set-aside designation and a completion date of October 31, 2025. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
HEPLISAV-B is a hepatitis B vaccine developed for adult immunization, with this order fulfilling federal medical supply requirements for military and veteran healthcare systems. The DLA leverages its Medical Supply Chain through its Troop Support organization to procure essential pharmaceutical products and vaccines to support defense health operations globally. AmerisourceBergen Drug Corp's capability to win this competitive award demonstrates its qualification to meet federal procurement requirements and reflects its established role as a critical vendor within the federal pharmaceutical distribution network, serving customers including the Defense Health Agency and U.S. Coast Guard among other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB26FL01C?
SPE2DB26FL01C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FL01C worth?
The government has obligated $71,611 on SPE2DB26FL01C.
Is contract SPE2DB26FL01C an order under another contract?
Yes. SPE2DB26FL01C is a delivery order under SPE2DB20D2002, an indefinite delivery contract.
Was contract SPE2DB26FL01C competed?
The extent of competition for SPE2DB26FL01C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award